Livzon Pharmaceutical Group (HK:1513) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Livzon Pharmaceutical Group has announced a change in leadership with the resignation of Mr. Yang Liang as Company Secretary and Authorized Representative, effective December 31, 2024. He will be succeeded by Ms. Liu Ning, whose extensive experience in the financial sector positions her well for this role. This transition is expected to maintain the company’s smooth operation and compliance with Hong Kong’s listing regulations.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Amazon (NASDAQ:AMZN) Carries on With Grocery Store Plans
- Ford (NYSE:F) Faces Multiple Product Recalls
- ‘Favorable Trends,’ Says Top Investor About Super Micro Computer Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
